A bone-saving drug could help breast cancer patients too – with less side effects
Cancer Breast Cancer osteoporosis

A bone-saving drug could help breast cancer patients too – with less side effects

Flávia Oliveira Geraldes
Flávia Oliveira Geraldes

In 10 seconds? Animal experiments have shown that a previously approved osteoporosis drug could be used to treat a subset of breast cancer, potentially with fewer side-effects than the current treatments.

What drug is that? It is a compound called lasofoxifene, which was developed for postmenopausal women to prevent the condition that makes bones brittle and break easily. Some non-pharmacological approaches (such as a diet rich in calcium and vitamin D and possibly some forms of exercise) might help prevent osteoporosis, but because some risk factors are non-modifiable (eg, older age and being female), there is still a need for pharmaceutical treatments for this disease, and that is why lasofoxifene was developed.

Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Personal

$99/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access 4 topic areas of your choosing
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
❌ Direct access to the Expert Network
❌ Your questions - answered by an Expert Scientist
❌ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
❌ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Professional

$3499/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
✅ Direct access to the Expert Network
✅ Your questions - answered by an Expert Scientist
✅ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
✅ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial